| 12116573 |
Targeting ligands for therapeutic compounds |
David B. Rozema, Darren H. Wakefield, Jonathan D. Benson, Zhen Li, Tao Pei +1 more |
2024-10-15 |
| 11840688 |
Compositions and methods for inhibiting gene expression of Hif2alpha |
So Wong, David L. Lewis, David B. Rozema, Darren H. Wakefield, Steven B. Kanner +7 more |
2023-12-12 |
| 10927373 |
Compositions and methods for inhibiting gene expression of Hif2alpha |
So Wong, David L. Lewis, David B. Rozema, Darren H. Wakefield, Steven B. Kanner +7 more |
2021-02-23 |
| 10246709 |
Targeting ligands for therapeutic compounds |
David B. Rozema, Darren H. Wakefield, Jonathan D. Benson, Zhen Li, Tao Pei +1 more |
2019-04-02 |
| 10059681 |
Disubstituted maleic anhydrides with altered kinetics of ring closure |
David B. Rozema, Jonathan D. Benson, Jeffrey C. Carlson |
2018-08-28 |
| 10047361 |
Disulfide-containing alkyne linking agents |
Aaron Almeida, Darren H. Wakefield, Jonathan D. Benson, David B. Rozema |
2018-08-14 |
| 10005815 |
Biologically cleavable tetrapeptide linking agents |
Jeffrey C. Carlson |
2018-06-26 |
| 9976141 |
Compositions and methods for inhibiting gene expression of Hif2alpha |
So Wong, David L. Lewis, David B. Rozema, Darren H. Wakefield, Steven B. Kanner +7 more |
2018-05-22 |
| 9803201 |
Disulfide-containing alkyne linking agents |
Aaron Almeida, Darren H. Wakefield, Jonathan D. Benson, David B. Rozema |
2017-10-31 |
| 9487556 |
Polyconjugates for delivery of RNAi triggers to tumor cells in vivo |
Weijun Cheng, So Wong, Aaron Almeida, David B. Rozema, Jeffrey C. Carlson |
2016-11-08 |
| 9481661 |
Disubstituted maleic anhydrides with altered kinetics of ring closure |
David B. Rozema, Jonathan D. Benson, Jeffrey C. Carlson |
2016-11-01 |
| 9107957 |
Peptide-based in vivo siRNA delivery system |
David B. Rozema, David L. Lewis, Darren H. Wakefield, Eric A. Kitas, Philipp Hadwiger +9 more |
2015-08-18 |
| 8802773 |
In vivo polynucleotide delivery conjugates having enzyme sensitive linkages |
David B. Rozema, David L. Lewis, Darren H. Wakefield, Eric A. Kitas, Philipp Hadwiger +9 more |
2014-08-12 |
| 8501930 |
Peptide-based in vivo siRNA delivery system |
David B. Rozema, Darren H. Wakefield, David L. Lewis, Jon Wolff, Jonathan D. Benson +9 more |
2013-08-06 |
| 8426554 |
In vivo polynucleotide delivery conjugates having enzyme sensitive linkages |
David B. Rozema, Darren H. Wakefield, David L. Lewis, Jon Wolff, Jonathan D. Benson +9 more |
2013-04-23 |
| 7491849 |
Oligoamine compounds and derivatives thereof for cancer therapy |
Aldonia Valasinas, Hirak S. Basu, Laurence J. Marton, Venodhar K. Reddy, Benjamin Frydman |
2009-02-17 |
| 7453011 |
Cycloalkyl substituted polyamines for cancer therapy and methods of synthesis therefor |
Benjamin Frydman, Aparajita Sarkar, Hirak S. Basu, Venodhar K. Reddy, Laurence J. Marton +2 more |
2008-11-18 |
| 7253207 |
Quinones as disease therapies |
Benjamin Frydman, Laurence J. Marton, Karen Neder, Jerry Sun |
2007-08-07 |
| 7235695 |
Cycloalkyl substituted polyamines for cancer therapy and methods of synthesis therefor |
Benjamin Frydman, Aldonia Valasinas, Aparajita Sarkar, Hirak S. Basu, Venodhar K. Reddy +2 more |
2007-06-26 |
| 7186825 |
Conformationally restricted polyamine analogs as disease therapies |
Benjamin Frydman, Laurence J. Marton, Venodhar K. Reddy, Aldonia Valasinas, Hirak S. Basu |
2007-03-06 |
| 7026347 |
Porphyrin-polyamine conjugates for cancer therapy |
Benjamin Frydman, Aldonia Valasinas, Venodhar K. Reddy, Hirak S. Basu, Aparajita Sarkar +3 more |
2006-04-11 |
| 6982351 |
Cycloalkyl substituted polyamines for cancer therapy and methods of synthesis therefor |
Benjamin Frydman, Aldonia Valasinas, Aparajita Sarkar, Hirak S. Basu, Venodhar K. Reddy +2 more |
2006-01-03 |
| 6809176 |
Quinones as disease therapies |
Benjamin Frydman, Laurence J. Marton, Karen Neder, Jerry Sun |
2004-10-26 |
| 6794545 |
Conformationally restricted polyamine analogs as disease therapies |
Benjamin Frydman, Laurence J. Marton, Venodhar K. Reddy, Aldonia Valasinas, Hirak S. Basu |
2004-09-21 |
| 6482943 |
Quinones as disease therapies |
Benjamin Frydman, Laurence J. Marton, Karen Neder, Jerry Sun |
2002-11-19 |